Obstetricians and psychiatrists are concerned about a recent FDA panel spreading misinformation about the potential harms of using SSRIs during pregnancy and postpartum.

President Trump wants to end homelessness in America. His plan? Make it easier to involuntarily treat people with serious ...

At a recent FDA panel on SSRIs in pregnancy, the chair suggested rising antidepressant use may be contributing to — not ...

The FDA is spreading lies about medications people need—and starting their attack by targeting pregnant women.

An unusual FDA panel on antidepressant use during pregnancy elevated clinicians and researchers who are deeply skeptical of ...

On Monday morning, the FDA hosted a 10-person expert panel on the use during pregnancy of SSRIs, which include medications ...

Democrats have accused Robert Kennedy Jr. of making claims without scientific research to back them and say his claims are ...

When the U.S. Food and Drug Administration (FDA) convened a public expert panel to review the use of selective serotonin ...

Nearly 50% of women who utilized antidepressant prescriptions before conception discontinued use after pregnancy without substitution of psychotherapy treatment, according to results of a cohort ...

The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its own. It was approved in 2019 to treat severe depression.

Learn the facts about taking antidepressants while pregnant, the risks of untreated depression, and how to make informed decisions for both maternal and baby wellness.

Key points Ketamine is a useful antidepressant that can be rapid and effective. Ketamine has not been shown to be safe during pregnancy. Clinics administering ketamine should give warnings about ...